{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:20:32Z","timestamp":1759774832420},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00464-018-06643-4","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T14:54:13Z","timestamp":1547132053000},"page":"3600-3604","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Laparoscopic vagal nerve blocking device explantation: case series and report of operative technique"],"prefix":"10.1007","volume":"33","author":[{"given":"Tarin C.","family":"Worrest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer G.","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin W.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"6643_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003641.pub4","author":"JL Colquitt","year":"2014","unstructured":"Colquitt JL, Pickett K, Loveman E, Frampton GK (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD003641.pub4\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"key":"6643_CR2","first-page":"291","volume":"9","author":"SS Hwang","year":"2016","unstructured":"Hwang SS, Takata MC, Fujioka K, Fuller W (2016) Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System. Med Dev (Auckland, NZ) 9:291\u2013299","journal-title":"Med Dev (Auckland, NZ)"},{"issue":"1","key":"6643_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11695-016-2278-x","volume":"27","author":"H Johannessen","year":"2017","unstructured":"Johannessen H, Revesz D, Kodama Y, Cassie N, Skibicka KP, Barrett P et al (2017) Vagal blocking for obesity control: a possible mechanism-of-action. Obes Surg 27(1):177\u2013185","journal-title":"Obes Surg"},{"issue":"1","key":"6643_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01655710","volume":"17","author":"JG Kral","year":"1993","unstructured":"Kral JG, Gortz L, Hermansson G, Wallin GS (1993) Gastroplasty for obesity: long-term weight loss improved by vagotomy. World J Surg 17(1):75\u201378; discussion 9","journal-title":"World J Surg"},{"issue":"11","key":"6643_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11695-012-0751-8","volume":"22","author":"MG Sarr","year":"2012","unstructured":"Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L et al (2012) The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg 22(11):1771\u20131782","journal-title":"Obes Surg"},{"issue":"1","key":"6643_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11695-016-2325-7","volume":"27","author":"CM Apovian","year":"2017","unstructured":"Apovian CM, Shah SN, Wolfe BM, Ikramuddin S, Miller CJ, Tweden KS et al (2017) Two-year outcomes of vagal nerve blocking (vBloc) for the treatment of obesity in the ReCharge trial. Obes Surg 27(1):169\u2013176","journal-title":"Obes Surg"},{"key":"6643_CR7","unstructured":"Inc E. Maestro Rechargeable System Instructions for Use FDA.gov2015 (2018) \n                    https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/p130019c.pdf"},{"issue":"1","key":"6643_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2014.16968","volume":"313","author":"DE Arterburn","year":"2015","unstructured":"Arterburn DE, Olsen MK, Smith VA, Livingston EH, Van Scoyoc L, Yancy WS Jr et al (2015) Association between bariatric surgery and long-term survival. JAMA 313(1):62\u201370","journal-title":"JAMA"},{"issue":"17","key":"6643_CR9","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","volume":"366","author":"PR Schauer","year":"2012","unstructured":"Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567\u20131576","journal-title":"N Engl J Med"},{"key":"6643_CR10","doi-asserted-by":"publisher","first-page":"365604","DOI":"10.1155\/2015\/365604","volume":"2015","author":"SA Shikora","year":"2015","unstructured":"Shikora SA, Wolfe BM, Apovian CM, Anvari M, Sarwer DB, Gibbons RD et al (2015) Sustained weight loss with vagal nerve blockade but not with Sham: 18-month results of the ReCharge trial. J Obes 2015:365604","journal-title":"J Obes"},{"key":"6643_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s11695-016-2143-y","volume":"26","author":"JM Morton","year":"2016","unstructured":"Morton JM, Shah SN, Wolfe BM, Apovian CM, Miller CJ, Tweden KS et al (2016) Effect of vagal nerve blockade on moderate obesity with an obesity-related comorbid condition: the ReCharge study. Obes Surg 26:983\u2013989","journal-title":"Obes Surg"},{"issue":"9","key":"6643_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jama.2014.10540","volume":"312","author":"S Ikramuddin","year":"2014","unstructured":"Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM et al (2014) Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA 312(9):915\u2013922","journal-title":"JAMA"},{"key":"6643_CR13","unstructured":"Summary of Safety and Effectiveness Data \n                    http:\/\/www.fda.gov2015\n                    \n                   [Homepage on the Internet]. Food and Drug Administration, Maryland [January 14, 2015]. \n                    https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/p130019b.pdf\n                    \n                  . Accessed 5 May 2018"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-018-06643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-018-06643-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-018-06643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T19:19:43Z","timestamp":1578597583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00464-018-06643-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["6643"],"URL":"https:\/\/doi.org\/10.1007\/s00464-018-06643-4","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"19 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Bruce Wolfe was a site investigator for the EMPOWER and ReCharge trials for ReShape Lifesciences. He received no financial remuneration for his role in the studies. Dr. Erin Gilbert was a co-investigator for the ReCharge trial for ReShape Lifesciences and received no financial remuneration for her role in the study. Drs. Worrest and Mattar have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}